OPVOYUS Trademark

Trademark Overview

On Thursday, February 4, 2016, a trademark application was filed for OPVOYUS with the United States Patent and Trademark Office. The USPTO has given the OPVOYUS trademark a serial number of 86897029. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, March 17, 2020. This trademark is owned by Bristol-Myers Squibb Company. The OPVOYUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
opvoyus

General Information

Serial Number86897029
Word MarkOPVOYUS
Filing DateThursday, February 4, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, March 17, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 9, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Thursday, May 21, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, May 21, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 26, 2019EXTENSION 5 GRANTED
Thursday, August 22, 2019EXTENSION 5 FILED
Monday, August 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 22, 2019TEAS EXTENSION RECEIVED
Friday, March 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2019EXTENSION 4 GRANTED
Wednesday, March 13, 2019EXTENSION 4 FILED
Wednesday, March 13, 2019TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 12, 2018EXTENSION 3 GRANTED
Wednesday, September 12, 2018EXTENSION 3 FILED
Wednesday, September 12, 2018TEAS EXTENSION RECEIVED
Wednesday, September 12, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 12, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 8, 2018EXTENSION 2 GRANTED
Thursday, March 8, 2018EXTENSION 2 FILED
Thursday, March 8, 2018TEAS EXTENSION RECEIVED
Friday, September 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2017EXTENSION 1 GRANTED
Wednesday, September 13, 2017EXTENSION 1 FILED
Wednesday, September 13, 2017TEAS EXTENSION RECEIVED
Tuesday, March 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 2, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 1, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2016NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2016NON-FINAL ACTION WRITTEN
Saturday, May 21, 2016ASSIGNED TO EXAMINER
Tuesday, February 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 8, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

opvoyus diseases pharmaceutical human anti preparations disorders organ solid auto immune